Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 972 of 5804
-
Sound and light training may bring back sight after stroke
Symptom relief Not yet recruitingThis study seeks to determine the extent of the visual capabilities that can be restored in hemianopic stroke patients by a multisensory training technique and evaluate changes in the brain that the training induces. The effectiveness of the technique will be evaluated in two int…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New stem cell filtering method could make transplants safer for kids
Disease control Not yet recruitingThis study is being done to see if the investigators can take peripheral blood stem cells from either an adult family member or a closely matched unrelated donor, and run them through a special lab instrument to remove alpha/beta T cells and B cells and then give them to the pati…
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New program aims to protect ugandan mothers and babies from HIV during pregnancy
Prevention Not yet recruitingStudy investigators developed and piloted a counselling intervention, Healthy Families-PrEP, that supports women to use HIV prevention strategies while trying for and during pregnancy. They will now adapt the intervention to community clinics and postpartum women and test the int…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Could shorter hormone therapy be just as effective for prostate cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to study definitive external beam radiation therapy together with drugs called androgen deprivation therapy (ADT) in patients with prostate cancer. The investigators want to find out if these drugs work the same way if they are given for 6 month…
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug cocktail aims to soothe ICU delirium and prevent breathing tubes
Symptom relief Not yet recruitingThis investigator-initiated, randomized, controlled, single-blind, superiority trial aims to assess the efficacy and safety of esketamine combined with dexmedetomidine for the management of agitation or delirium in intensive care unit (ICU) patients receiving non-invasive respira…
Phase: PHASE4 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can switching ventilator mode early save lives? new trial aims to find out
Disease control Recruiting nowEARLY-VENT is a multicenter, open-label, three-period cluster-randomized crossover trial designed to evaluate whether early transition from controlled to assisted ventilation improves outcomes in critically ill patients. The study will enroll approximately 1,600 adult patients ac…
Phase: NA • Sponsor: Southeast University, China • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug targets rare nerve tumors in people with specific gene loss
Disease control Not yet recruitingPeople who have a cancer called MPNST, or Malignant Peripheral Nerve Sheath Tumor, may be eligible for this study. The purpose of this study is to see if a new medicine called BMS-986504 may work better than other available medicines for people with MPNST. Methylthioadenosine Pho…
Phase: PHASE1, PHASE2 • Sponsor: Ankit Mangla, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can brain scans and genetics predict autism and ADHD before symptoms appear?
Knowledge-focused Not yet recruitingThe PUREMIND OS1/OS2 study is a multinational, prospective, longitudinal observational study designed to identify early neurophysiological, biological, environmental, and psychosocial markers associated with neurodevelopmental and mental health conditions from infancy through you…
Sponsor: University of Exeter • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New sciatica shot could offer lasting pain relief
Symptom relief Not yet recruitingThis is a research study of SP-102, an experimental medication designed to relieve pain in patients with moderate to severe sciatica (pain in the lower back, hips, buttocks and legs). SP-102, placebo (a medication that looks like SP-102 but does not contain any active ingredient)…
Phase: PHASE3 • Sponsor: Semnur Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Neck injection aims to fix PTSD sleep problems
Symptom relief Not yet recruitingPost-traumatic stress disorder (PTSD) is a chronic disorder that develops following exposure to trauma, and is characterized by intrusive experiences, avoidance, cognitive-emotional changes, and hyperarousal. It is based on a complex noradrenergic dysregulation. The amygdala acti…
Phase: NA • Sponsor: sara dichtwald • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a common antibiotic ease Kids' bowel disease?
Disease control Not yet recruitingThe goal of this clinical trial is to learn how oral vancomycin therapy may contribute in treating paediatric inflammatory bowel disease, particularly atypical ulcerative colitis and PSC-associated colitis. It will also give more information on how this treatment affects gut micr…
Phase: PHASE2 • Sponsor: Tampere University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can intense breathing training boost lung power and ease fatigue in MS?
Disease control Not yet recruitingMultiple sclerosis (MS) is a chronic disease affecting the central nervous system, characterized by inflammation, demyelination, and axonal degeneration, and primarily affects young adults. Muscle weakness, sensory disturbances, spasticity, pain, visual impairment, ataxia, fatigu…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Chemotherapy drug temozolomide under review for tough pituitary tumors
Disease control Not yet recruitingTemozolomide is the main chemotherapy drug used for aggressive pituitary tumors and pituitary carcinomas that do not respond to standard treatments like surgery or radiation. Most of what is known about how well this treatment works comes from small studies in Europe and the Unit…
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could rapid brain zaps sharpen thinking in Parkinson's?
Symptom relief Recruiting nowThe goal of this study is to determine the whether a short-term, high-dose form of non-invasive brain stimulation (intermittent theta burst stimulation; iTBS) is a promising and safe treatment for mild cognitive impairment in Parkinson's disease (PD-MCI).
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could Urine-Derived exosomes or ozone therapy restore erections after prostate cancer surgery?
Disease control Not yet recruitingThis prospective, randomized, controlled trial aims to evaluate and compare the therapeutic efficacy of intracavernosal urine-derived exosomes and systemic rectal ozone therapy in patients experiencing erectile dysfunction (ED) post-robotic-assisted radical prostatectomy (RARP). …
Phase: NA • Sponsor: Medipol University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Smartphone program aims to boost hope and recovery in oral cancer survivors
Symptom relief Not yet recruitingThe goal of this study (exploratory sequential design; mixed-methods study) is to evaluate whether a PERMA-H model mobile-based rehabilitation support program delivered to post-tracheostomy oral cancer patients can improve psychological and rehabilitation outcomes, compared with …
Phase: NA • Sponsor: Hainan Medical College • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New sleep drug aims to help Parkinson's patients get a good Night's rest
Symptom relief Not yet recruitingThis study will use sleep parameters measured by polysomnography (PSG) as the primary means to evaluate the efficacy and safety of dimdazenil, a GABAA receptor partial agonist, in treating insomnia in Parkinson's disease patients.
Sponsor: Second Affiliated Hospital of Soochow University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Could a 30-Day blood thinner regimen prevent clots after spine cancer surgery?
Disease control Not yet recruitingPeople who have surgery on their spine to treat cancer that has spread (metastatic disease) have a high chance of developing dangerous blood clots in the legs or lungs. These blood clots are called deep vein thrombosis (DVT) or pulmonary embolism (PE). In a review of patients at …
Phase: PHASE4 • Sponsor: James Bayley • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could early lipid screening in High-Risk kids prevent future heart attacks?
Knowledge-focused Recruiting nowPreventive measures are increasingly coming to the forefront of medicine. Many of these measures can be implemented as early as childhood and adolescence. For instance, the early detection and treatment of cardiovascular risk factors can significantly reduce long-term morbidity a…
Phase: NA • Sponsor: Alexandra Miriam Kiess • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Personalized pressure injury prevention put to the test in surgery trial
Disease control Not yet recruitingThis study evaluates whether a risk-based perioperative pressure injury prevention bundle reduces the development of pressure injuries in patients undergoing elective surgery lasting 3 hours or longer. Pressure injuries that develop during and after surgery are a common patient …
Phase: NA • Sponsor: Acibadem University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC